Table 2.
Graft Survival Rate at 1-, 2-, 3-, 5-, and 10-year After Penetrating Keratoplasty per Geographic Region†
| Graft Survival Rate | Year After Transplant |
Reference | ||||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 5 | 10 | ||
| Global Average | 88.6 | 81.2 | 78.9 | 72.8 | 61.2 | |
|
| ||||||
| NORTH AMERICA | ||||||
|
| ||||||
| Canada | 79 | 65 | Sit et al (41) | |||
| United States | 97 | 95 | 94 | 91 | Price et al (34) | |
| United States | 78 | 76 | Ahmad et al (40) | |||
| United States | 86 | 77 | Dunn et al (37) | |||
| United States | 90 | 82 | Thompson et al (38) | |||
| United States | 93 | 70 | 61 | 48 | Ing et al (14) | |
| United States | 92 | 70 | 60 | 46 | Patel et al (35) | |
| Regional Average | 94 | 87 | 78 | 76 | 63 | |
|
| ||||||
| EUROPE | ||||||
|
| ||||||
| Europe | 88 | Dunker et al (81) | ||||
| France | 79 | 73 | 59 | 50 | Muraine et al (62) | |
| Italy | 95 | 88 | 75 | Fasolo et al (56) | ||
| Italy | 83 | Fasolo et al (57) | ||||
| Netherlands | 96 | 90 | Dickman et al (67) | |||
| Spain | 65 | Barraquer et al (68) | ||||
| Spain | 85 | 71 | 67 | Montesel et al (70) | ||
| Sweden | 71 | Claesson et al (140) | ||||
| UK | 89 | Vail et al (53) | ||||
| UK | 82 | Rahman et al (47) | ||||
| UK | 93 | Figueiredo et al (54) | ||||
| UK | 90 | 81 | 66 | Beckingsale et al (55) | ||
| Regional Average | 88 | 88 | 76 | 75 | 62 | |
|
| ||||||
| ASIA | ||||||
|
| ||||||
| China | 94 | 80 | Pan et al (99) | |||
| China | 95 | 88 | 76 | Li et al (103) | ||
| India | 80 | 69 | 47 | Dandona et al (2) | ||
| India | 65 | 53 | Joshi et al (82) | |||
| India | 67 | 59 | Arya et al (83) | |||
| Japan | 72 | Inoue et al (106) | ||||
| Pakistan | 80 | 76 | 51 | Chaudhary et al (91) | ||
| Singapore | 87 | 72 | 64 | 52 | Tan et al (109) | |
| Singapore | 67 | Ang et al (116) | ||||
| Singapore | 91 | 67 | 55 | Anshu et al (110) | ||
| Singapore | 94 | 80 | 72 | Arundhati et al (117) | ||
| Thailand | 92 | 76 | 63 | 45 | Reinprayoon et al (115) | |
| Regional Average | 85 | 71 | 75 | 63 | 59 | |
|
| ||||||
| AFRICA | ||||||
|
| ||||||
| Ethiopia | 89 | 80 | Ayalew et al (122) | |||
| Ethiopia | 77 | Tilahun et al (121) | ||||
| Kenya | 86 | Chen et al (126) | ||||
| Kenya | 82 | Hydara et al (124) | ||||
| Kenya | 65 | Yorston et al (118) | ||||
| Regional Average | 88 | 76 | ||||
|
| ||||||
| MIDDLE EAST | ||||||
|
| ||||||
| Israel | 94 | 90 | 88 | 81 | Sternfeld et al (144) | |
| Saudi Arabia | 97 | 90 | 86 | 81 | Wagoner et al (128) | |
| Saudi Arabia | 91 | 84 | Omar et al (129) | |||
| Regional Average | 96 | 90 | 88 | 82 | ||
|
| ||||||
| AUSTRALIA | ||||||
|
| ||||||
| Australia | 81 | 65 | Bishop et al (194) | |||
| Australia | 91 | 79 | Williams et al (157) | |||
| Australia | 91 | 79 | 72 | Williams et al (158) | ||
| Australia | 86 | 73 | 62 | Williams et al (149) | ||
| Australia | 87 | 73 | 60 | Williams et al (150) | ||
| Australia | 94 | Green et al (156)g | ||||
| New Zealand | 87 | Patel et al (153) | ||||
| Regional Average | 89 | 81 | 79 | 71 | 61 | |
|
| ||||||
| CENTRAL AND SOUTH AMERICA | ||||||
|
| ||||||
| Colombia | 83 | 81 | 80 | Mora et al (171) | ||
†
Graft survival rates included are for primary grafts only